Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,229-9,240 of 23,847
Drug study icon
CompletedNCT03265808

Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Addiction and Major Depression.

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand whether this type of care can work better when mental health difficulties overlap with substance use.

In Harlingen
Depression, AddictionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
Ihsan M Salloum, MD, MPH
Condition
Depression, Addiction
Drug study icon
CompletedNCT00643123

Allopurinol Add-on Treatment for Refractory Mania

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Los Angeles
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Cedars-Sinai Medical Center
Condition
Bipolarity
Drug study icon
TerminatedNCT00732251

Allopurinol Maintenance Study for Bipolarity

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

In Los Angeles
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Cedars-Sinai Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT03367533

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, study

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In New Haven
PTSD, Depression, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
PTSD, Depression, ...
Drug study icon
CompletedNCT03788759

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Fortaleza
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Condition
Schizophrenia
Drug study icon
CompletedNCT01411813

Alprazolam and Eating Behavior in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Eating disordersOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Eating disorders
Behavioral study icon
CompletedNCT07045818

Altered Interhemispheric DLPFC Coordination and Cardiac Hyperreactivity During Multisensory Aversive Challenge in Recurrent Pregnancy Loss With Comorbid Anxiety

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Shenyang
AnxietyBehavioralFrom 18 Years to 45 Years
Countries
China
Sponsor
Shenyang Medical College
Condition
Anxiety
Device study icon
UnknownNCT06320028

Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms

This study is looking at whether a digital support tool can help people with major depression or Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Tucson
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States
Sponsor
University of Arizona
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.